Indication
Becker Muscular Dystrophy
7 clinical trials
5 products
1 drug
Clinical trial
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of EDG-5506 on Safety, Biomarkers, Pharmacokinetics, and Functional Measures in Adults and Adolescents With Becker Muscular DystrophyStatus: Recruiting, Estimated PCD: 2026-06-01
Product
EDG-5506Product
PlaceboClinical trial
An Open-Label Extension Study to Assess the Long-term Effect of EDG-5506 on Safety, Biomarkers, and Functional Measures in Adults and Adolescents With Becker Muscular DystrophyStatus: , Estimated PCD: 2028-03-01
Product
VamoroloneClinical trial
A Phase II Pilot Trial of Vamorolone vs. Placebo for the Treatment of Becker Muscular DystrophyStatus: Recruiting, Estimated PCD: 2025-01-31
Clinical trial
A Phase 1b, Open-label Study of the Safety and Pharmacokinetics of EDG-5506 in Adults With Becker Muscular DystrophyStatus: Completed, Estimated PCD: 2024-03-01
Clinical trial
Phase I Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis.Status: Completed, Estimated PCD: 2017-10-01
Product
rAAV1.CMV.huFollistatin344Clinical trial
Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD)Status: Recruiting, Estimated PCD: 2025-12-01
Product
Genetic characterizationClinical trial
Open Label Safety and Efficacy of Once Weekly Steroid in Patients With LGMD and Becker Muscular DystrophyStatus: Completed, Estimated PCD: 2020-06-01
Drug
R-CHOP